BWX Technologies Inc banner

BWX Technologies Inc
NYSE:BWXT

Watchlist Manager
BWX Technologies Inc Logo
BWX Technologies Inc
NYSE:BWXT
Watchlist
Price: 229.57 USD -0.31% Market Closed
Market Cap: $21B

BWX Technologies Inc
Investor Relations

BWX Technologies Inc. is a formidable force in the sphere of nuclear solutions, with its roots deeply embedded in providing critical components for both commercial and government applications. Its rich legacy traces back to the mid-20th century, initially contributing to the U.S. naval nuclear program. Today, BWX Technologies harnesses its vast experience and technological prowess to deliver high-performance nuclear reactors, fuel, and assemblies for the U.S. Navy’s fleet of aircraft carriers and submarines, which forms a significant portion of its business. This steady flow of government contracts not only underpins its revenue stream but also positions the company as a national defense stalwart.

On the commercial side, BWX Technologies has diversified its operations, venturing into nuclear medicine as well as the provision of nuclear fuel services. This includes producing and managing next-generation nuclear energy solutions, focusing on small modular reactors and other advanced technologies. By fulfilling the growing demand for cleaner energy solutions and the expanding field of nuclear medicine, BWX Technologies effectively taps into future-facing industries, endeavoring to streamline more sustainable and efficient technological innovations. The company’s meticulous focus on both the secure execution of its government contracts and the expansive potential of commercial nuclear applications forms a strategic blueprint for sustained growth in a fluctuating global landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 23, 2026
AI Summary
Q4 2025

Record Year: BWXT delivered record results in 2025, with revenue up 18%, adjusted EBITDA up 15%, EPS up 20%, and free cash flow up 16%, all exceeding initial guidance.

Strong Backlog: Backlog reached $7.3 billion, up 50% year-over-year, fueled by both government and commercial segments.

Commercial Momentum: Commercial operations revenue surged 95% in Q4 (31% organic), with backlog up 85% to $1.7 billion, supported by CANDU, SMR projects, and medical growth.

2026 Outlook: Guidance calls for revenue of approximately $3.75 billion (up high teens), adjusted EBITDA of $645–660 million, and EPS of $4.55 to $4.70, with another year of significant growth expected.

Margin Dynamics: Government margins are expected to dip in 2026 due to new program ramps but rebound in 2027; commercial margins set to improve by about 100 bps in 2026.

Strategic Investments: Significant capital invested in capacity expansion, technology, and acquisitions (A.O.T. and Kinectrics), plus a $1.25 billion convertible debt deal to enhance financial flexibility.

AI & Automation: BWXT advancing internal AI use from manufacturing process optimization to plant automation, aiming for fully digitized quality records and digital twins.

Order Visibility: Management confident about demand for SMRs, AP1000, and medical isotopes, with expectations of further orders and growth across all markets in coming years.

Key Financials
Revenue
$886 million
Adjusted EBITDA
$148 million
Earnings Per Share
$1.08
Free Cash Flow
$57 million (Q4), $295 million (full year)
Backlog
$7.3 billion
Commercial Backlog
$1.7 billion
Capital Expenditures
$185 million (2025)
Adjusted Effective Tax Rate
19.5% (Q4), 20.4% (2025 full year)
Government Operations Adjusted EBITDA Margin
18.8% (Q4), 20.4% (full year)
Commercial Operations Adjusted EBITDA
$44 million (Q4)
Commercial Operations Adjusted EBITDA Margin
14.9% (Q4)
BWXT Medical Annual Revenue
slightly more than $100 million
Liquidity
$1.7 billion at year-end
Earnings Call Recording
Other Earnings Calls

Management

Mr. Rex D. Geveden
President, CEO & Director
No Bio Available
Mr. Robb A. LeMasters
CFO & Executive VP
No Bio Available
Mr. Robert L. Duffy
Senior VP & Chief Administrative Officer
No Bio Available
Mr. Kevin M. McCoy
President of Government Operations Segment
No Bio Available
Mr. Omar Fathi Meguid
Senior VP & Chief Digital Officer
No Bio Available
Mr. Michael Fitzgerald
VP of Finance & Chief Accounting Officer
No Bio Available
Mr. Chase Jacobson
Vice President of Investor Relations
No Bio Available
Mr. Ronald O. Whitford Jr.
Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
No Bio Available
Ms. Suzanne C. Sterner
Senior VP & Chief Corporate Affairs Officer
No Bio Available
Mr. John R. MacQuarrie
President of Commercial Operations Segment
No Bio Available

Contacts

Address
VIRGINIA
Lynchburg
800 Main St Ste 4
Contacts
+19803654300.0
www.bwxt.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett